(185 days)
Not Found
No
The description focuses on the chemical composition and intended use of a preservation solution, with no mention of AI or ML.
No.
The device is a preservation solution used for flushing and cold storage of organs before transplantation, which is a supportive role rather than directly treating a disease or condition in a patient.
No
CoStorSol® is described as a solution for flushing and cold storage of organs for transplantation, not for diagnosing medical conditions.
No
The device description clearly states that CoStorSol® is a sterile, non-pyrogenic solution packaged in 1-liter bags, indicating it is a physical substance and not software.
Based on the provided information, this device is NOT an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states that CoStorSol® is for the "flushing and cold storage of kidney, liver and pancreas organs at the time of organ removal from the donor in preparation for storage, transportation and eventual transplantation into a recipient." This describes a process performed outside of the body to preserve organs for transplantation.
- Device Description: The description details a solution used for organ preservation, not for analyzing samples taken from the body to diagnose a condition.
- Lack of IVD Characteristics: There is no mention of analyzing biological samples (blood, urine, tissue, etc.) or providing diagnostic information about a patient's health status.
IVD devices are specifically designed to examine specimens derived from the human body to provide information for the diagnosis, monitoring, or treatment of diseases or conditions. CoStorSol®'s function is entirely focused on preserving organs for transplantation, which is a therapeutic procedure, not a diagnostic one.
N/A
Intended Use / Indications for Use
CoStorSol® is intended for the flushing and cold storage of kidney, liver and pancreas organs at the time of organ removal from the donor in preparation for storage, transportation and eventual transplantation into a recipient.
Product codes
KDL, KDN
Device Description
Preservation Solutions, Inc. manufacturers CoStorSol® according to a "recipe" pioneered at the University of Wisconsin by Dr. Folkert O. Belzer. The cold storage solution is still referred to as "Belzer UW" solution, even though it has been marketed under the trade name ViaSpan®. The formulation includes soluble colloids, buffers, sodium and postassium salts, redox stabilizers, and phosphoric compounds to aid tissue viability by enabling regeneration of adenosine triphosphate (ATP).
CoStorSol® is a clear to light yellow, sterile, non-pyrogenic solution for hypothermic flushing and storage of organs. The solution is packaged in 1-liter bags.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
kidney, liver and pancreas organs
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Test results have shown CoStorSol® itself to be a biocompatible solution, supplied in flexible solution administration pouches, which have likewise been tested and shown to be biocompatible. The ISO 10993 series of standards were referenced during the planning and execution of all biocompatibility testing. CoStorSol® is supplied sterile and non-pyrogenic in order to assure safety for transplant recipients. Sterilization processes were validated according to either ISO 17665 or USP Section , as appropriate.
Chemical analyses on both fresh and aged samples of CoStorSol® show it to be identical to the predicate solution. Furthermore, Fourier transformed infrared scans confirmed stability and chemical identity for the CoStorSol® product.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 876.5880 Isolated kidney perfusion and transport system and accessories.
(a)
Identification. An isolated kidney perfusion and transport system and accessories is a device that is used to support a donated or a cadaver kidney and to maintain the organ in a near-normal physiologic state until it is transplanted into a recipient patient. This generic type of device may include tubing, catheters, connectors, an ice storage or freezing container with or without bag or preservatives, pulsatile or nonpulsatile hypothermic isolated organ perfusion apparatus with or without oxygenator, and disposable perfusion set.(b)
Classification. Class II (performance standards).
0
K073693
182
510(k) SUMMARY
SUBMITTER INFORMATION
- A. Company Name: Preservation Solutions Inc.
- B. Company Address: 980 Proctor Drive Elkhorn, Wisconsin 32121
- C. Company Phone: 262 723 6715
- D. Company Facsimile: 262 723 4013
- E. Contact Person: William Wagner Quality Assurance Director
DEVICE IDENTIFICATION
- A. Device Trade Name: CoStorSol®
- B. Device Common Name: Organ Storage Solution
- C. Classification Name: Organ Storage Solution systems and accessories
- D. Class II (21 CRF 876.5880)
- E. Device Code: KDL
IDENTIFICATION OF PREDICATE DEVICES
CoStorSol® is a cold storage solution for harvested organs, which is substantially equivalent to a ViaSpan® solution (K944866).
JUL - 3 2008
1
K073693
2 of 2
DEVICE DESCRIPTION
Preservation Solutions, Inc. manufacturers CoStorSol® according to a "recipe" pioneered at the University of Wisconsin by Dr. Folkert O. Belzer. The cold storage solution is still referred to as "Belzer UW" solution, even though it has been marketed under the trade name ViaSpan®. The formulation includes soluble colloids, buffers, sodium and postassium salts, redox stabilizers, and phosphoric compounds to aid tissue viability by enabling regeneration of adenosine triphosphate (ATP).
CoStorSol® is a clear to light yellow, sterile, non-pyrogenic solution for hypothermic flushing and storage of organs. The solution is packaged in 1-liter bags.
INDICATIONS FOR USE
CoStorSol® is intended for the flushing and cold storage of kidney, liver and pancreas organs at the time of organ removal from the donor in preparation for storage, transportation and eventual transplantation into a recipient.
COMPARISON TO PREDICATE DEVICES
ViaSpan® (Belzer - UW) Organ Solution, cleared under 510(k) K944866 serves as an exact predicate for Preservation Solutions, Inc.'s CoStorSol®, in that it is an identical solution with exactly the same intended use and chemical composition. CoStorSol® and the predicate solution, Viaspan®, are both supplied in 1-liter flexible bags to ease connection to standard administration sets for flushing of harvested organs. The two solutions are designed for refrigerated storage without freezing, and for use cold. Both are used as a vasculature flush medium for an organ then as a cold storage medium.
BIOCOMPATIBILITY, STERILIZATION, PACKAGING, AND BENCH TESTING
Test results have shown CoStorSol® itself to be a biocompatible solution, supplied in flexible solution administration pouches, which have likewise been tested and shown to be biocompatible. The ISO 10993 series of standards were referenced during the planning and execution of all biocompatibility testing. CoStorSol® is supplied sterile and non-pyrogenic in order to assure safety for transplant recipients. Sterilization processes were validated according to either ISO 17665 or USP Section , as appropriate.
Chemical analyses on both fresh and aged samples of CoStorSol® show it to be identical to the predicate solution. Furthermore, Fourier transformed infrared scans confirmed stability and chemical identity for the CoStorSol® product.
CONCLUSION
The above statements establish substantial equivalence between CoStorSol® and the cited predicate.
2
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle or bird-like symbol with three curved lines representing its wings or body. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular fashion around the bird symbol.
Public Health Service
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Preservation Solutions, Incorporated % Mr. Neil Burris Neil Burris and Associates 4250 Grove Street DENVER CO 80211
Re: K073693
Trade/Device Name: CoStorSol® Regulation Number: 21 CFR 876.5880 Regulation Name: Isolated kidney perfusion and transport system and accessories Regulatory Class: II Product Code: KDN Dated: June 13, 2008 Received: June 17, 2008
Dear Mr. Burris:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
3
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. Your of t comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements is set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act), 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permotto your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance to one of the following numbers, based on the regulation number at the top of this letter.
| 21 CFR 876.xxxx | (Gastroenterology/Renal/Urology) | 240-276-0115 |
|---|---|---|
| 21 CFR 884.xxxx | (Obstetrics/Gynecology) | 240-276-0115 |
| 21 CFR 892.xxxx | (Radiology) | 240-276-0120 |
| Other | 240-276-0100 |
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRF's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at 24/02/6 3474. For questions regarding the reporting of device adverse events (Medical Device Leporting (MDR)), please contact the Division of Surveillance Systems at 240-276-3464. You may other other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) or 38-2011 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.2011 0.1
Sincerely yours.
Nancy C. Brogdon
Nancy C. Brogdon . Director, Division of Reproductive. Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
4. Statement of Indication for Use
Device Name: CoStorSol®
Indications for Use
CoStorSol® is intended for the flushing and cold storage of kidney, liver and pancreas organs at the time of organ removal from the donor in preparation for storage, transportation and eventual transplantation into a recipient.
Prescription Use XXXX (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Helentlemen
(Division Sign-Off) Division of Reproductive, Abdominal, and Radiological Devices
510(k) Number __